UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING

The Journal of clinical investigation, 2020-04, Vol.130 (4), p.1635-1652

2020

Volltextzugriff (PDF)

T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic response

Oncoimmunology, 2018-11, Vol.7 (11), p.e1494112-e1494112

2018

Volltextzugriff (PDF)

PD-1 Status in CD8 + T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer

Cancer research (Chicago, Ill.), 2017-11, Vol.77 (22), p.6353-6364

2017

Volltextzugriff (PDF)

HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING

The Journal of clinical investigation, 2020-04, Vol.130 (4), p.1635-1652

2020

Volltextzugriff (PDF)

Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals

Clinical cancer research, 2018-01, Vol.24 (1), p.62-72

2018

Volltextzugriff (PDF)

HPV-associated head and neck cancer is characterized by distinct profiles of CD8+ T cells and myeloid-derived suppressor cells

Cancer Immunology, Immunotherapy, 2023-12, Vol.72 (12), p.4367-4383

2023

Volltextzugriff (PDF)

The bidirectional tumor--mesenchymal stromal cell interaction promotes the progression of head and neck cancer

Stem cell research & therapy, 2014-08, Vol.5 (4), p.95-95, Article 95

2014

Volltextzugriff (PDF)

Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma

Immunobiology (1979), 2017-01, Vol.222 (1), p.66-74

2017

Volltextzugriff (PDF)

EGFR-targeted mAb therapy modulates autophagy in head and neck squamous cell carcinoma through NLRX1–TUFM protein complex

Oncogene, 2016-09, Vol.35 (36), p.4698-4707

2016

Volltextzugriff (PDF)

HPV16 drives cancer immune escape via NLRXI-mediated degradation of STING

The Journal of clinical investigation, 2020-04, Vol.130 (4), p.1635

2020

Volltextzugriff (PDF)

Immune Escape and Immunotherapy of HPV-Related Oropharyngeal Cancer: Has the Future Arrived?

Current otorhinolaryngology reports, 2015-06, Vol.3 (2), p.63-72

2015

Volltextzugriff (PDF)

Anti-EGFR mAb cetuximab therapy increases T cell receptor

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2)

2015

Volltextzugriff (PDF)

Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P73-P73, Article P73

2015

Volltextzugriff (PDF)

A Phase Ib study of neoadjuvant immune biomarker modulation with cetuximab and motolimod in head and neck cancer (HNC)

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P144-P144

2015

Volltextzugriff (PDF)

Level of PD-1 expression on CD8+ T cells influence prognosis and respond to PD-1 therapy in a murine model

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P228-P228, Article P228

2015

Volltextzugriff (PDF)

Das klinische Breast Cancer Recruitment Module (BCRM) – Online-Screening-Instrument zur Unterstützung von Tumorkonferenzen

Senologie (Stuttgart), 2012-10, Vol.9 (3), p.155-157

2012

Volltextzugriff (PDF)

Proof-of-Principle: Online-Screening-Instrument. Breast Cancer Recruitment Module – Unterstützung bei Patientenauswahl für adjuvante Therapiestudien

Geburtshilfe und Frauenheilkunde, 2012-07, Vol.72 (7), p.575-577

2012

Volltextzugriff (PDF)

Immunology of Head and Neck Cancer

Head and Neck Cancer, 2016, p.133-148

2016

Volltextzugriff (PDF)

PD-L1 Mediates Dysfunction in Activated PD-1 + NK Cells in Head and Neck Cancer Patients

Cancer immunology research, 2018-12, Vol.6 (12), p.1548-1560

2018

Volltextzugriff (PDF)

Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab

Frontiers in oncology, 2021-05, Vol.11, p.635096-635096

2021

Volltextzugriff (PDF)

Evaluation of Immunoregulatory Biomarkers on Plasma Small Extracellular Vesicles for Disease Progression and Early Therapeutic Response in Head and Neck Cancer

Cells (Basel, Switzerland), 2022-03, Vol.11 (5), p.902

2022

Volltextzugriff (PDF)

Extrakranielle Schwannome im Kopf-Hals-Bereich: Klinische Implikationen anhand von 20 Fällen

Laryngo- rhino- otologie, 2017-09, Vol.96 (9), p.607-614

2017

Volltextzugriff (PDF)

B-Helper Neutrophils in Regional Lymph Nodes Correlate with Improved Prognosis in Patients with Head and Neck Cancer

Cancers, 2021-06, Vol.13 (12), p.3092

2021

Volltextzugriff (PDF)

Expression Patterns of CD44 and AREG Under Treatment With Selective Tyrosine Kinase Inhibitors in HPV + and HPV - Squamous Cell Carcinoma

Cancer genomics & proteomics, 2020-09, Vol.17 (5), p.579-585

2020

Volltextzugriff (PDF)

Cervical lymph node diseases in children

GMS current topics in otorhinolaryngology, head and neck surgery, 2014, Vol.13, p.Doc08-Doc08

2014

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(28)
Buchkapitel
(2)

Sprache

Englisch
(25)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING

T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic response

PD-1 Status in CD8 + T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer

HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING

Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals

HPV-associated head and neck cancer is characterized by distinct profiles of CD8+ T cells and myeloid-derived suppressor cells

The bidirectional tumor--mesenchymal stromal cell interaction promotes the progression of head and neck cancer

Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma

EGFR-targeted mAb therapy modulates autophagy in head and neck squamous cell carcinoma through NLRX1–TUFM protein complex

HPV16 drives cancer immune escape via NLRXI-mediated degradation of STING

Immune Escape and Immunotherapy of HPV-Related Oropharyngeal Cancer: Has the Future Arrived?

Anti-EGFR mAb cetuximab therapy increases T cell receptor

Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment

A Phase Ib study of neoadjuvant immune biomarker modulation with cetuximab and motolimod in head and neck cancer (HNC)

Level of PD-1 expression on CD8+ T cells influence prognosis and respond to PD-1 therapy in a murine model

Das klinische Breast Cancer Recruitment Module (BCRM) – Online-Screening-Instrument zur Unterstützung von Tumorkonferenzen

Proof-of-Principle: Online-Screening-Instrument. Breast Cancer Recruitment Module – Unterstützung bei Patientenauswahl für adjuvante Therapiestudien

Immunology of Head and Neck Cancer

PD-L1 Mediates Dysfunction in Activated PD-1 + NK Cells in Head and Neck Cancer Patients

Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab

Evaluation of Immunoregulatory Biomarkers on Plasma Small Extracellular Vesicles for Disease Progression and Early Therapeutic Response in Head and Neck Cancer

Extrakranielle Schwannome im Kopf-Hals-Bereich: Klinische Implikationen anhand von 20 Fällen

B-Helper Neutrophils in Regional Lymph Nodes Correlate with Improved Prognosis in Patients with Head and Neck Cancer

Expression Patterns of CD44 and AREG Under Treatment With Selective Tyrosine Kinase Inhibitors in HPV + and HPV - Squamous Cell Carcinoma

Cervical lymph node diseases in children

Suchergebnisse filtern